Supmed Pharmaceutical Private Limited
About Supmed Pharmaceutical Private Limited
Data last updated:
Supmed Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 November 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52310DL2022PTC406534.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Navin Kumar Verma and Praveen Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 2/944 F/F Kh No. 97 & 98 Gali No. 43A Som Bazar Pusta – 4 1/2 Gamri Ext., Delhi, India – 110053.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.8 Lakh, a decline of 45% compared to the previous year. For the same year it recorded a net profit of ₹1.72 Lakh (net margin 95.6%) and EBITDA of ₹1.72 Lakh (EBITDA margin 95.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Supmed Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered AddressA – 2/944 F/F Kh No. 97 & 98 Gali No. 43A Som Bazar Pusta – 4 1/2 Gamri Ext., Delhi, India – 110053
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Supmed Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Supmed Pharmaceutical Private Limited, buy the company report.
Financials of Supmed Pharmaceutical Private Limited
FY 2025 filings availableSupmed Pharmaceutical Private Limited reported revenue of ₹1.8 Lakh (down 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 45% in the latest year. EBITDA rose 170% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.72 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.72 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 95.6% | ||
| Net Profit Margin | 95.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Supmed Pharmaceutical Private Limited, buy the company report.
Board of directors of Supmed Pharmaceutical Private Limited
Supmed Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navin Kumar Verma | Director | 04 Nov 2022 | 4 Years 0 Months | Current |
| Praveen Kumar | Director | 04 Nov 2022 | 4 Years 0 Months | Current |
Peer comparison
Supmed Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Milestone Steels Private Limited | ₹1.8 Lakh (FY 2019) | 1616.0% | Delhi, India | |||
| Healthy Organics and Foods Private Limited | ₹1.8 Lakh (FY 2025) | 4.0% | Greater Noida, Uttar Pradesh, India | |||
| Victoria Wines Private Limited | ₹1.8 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Sui Generis Innovations Private Limited | ₹1.8 Lakh (FY 2016) | New Delhi, Delhi, India | ||||
| Mungasaji Krupa Patil Multi Enterprises Private Limited | ₹1.8 Lakh (FY 2018) | -67.0% | Nagpur, Maharashtra, India | |||
| Supmed Pharmaceutical Private Limitedthis company | ₹1.8 Lakh (FY 2025) | ₹1.72 Lakh | 95.6% | -45.0% | Delhi, India | |
| Spoxy Plant & Machinery Suppliers Private Limited | ₹1.8 Lakh (FY 2024) | -11.0% | Kolkata, West Bengal, India | |||
| Kema Herbam Private Limited | ₹1.8 Lakh (FY 2024) | -48.0% | Kota, Rajasthan, India | |||
| Mogra Designs Private Limited (OPC) | ₹1.8 Lakh (FY 2019) | -94.0% | Pune, Maharashtra, India | |||
| Balaji Polyfoams Private Limited | ₹1.8 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Enekar Herbaceuticals Private Limited | ₹1.8 Lakh (FY 2020) | Jalgaon, Maharashtra, India |
To see the full peer comparison of Supmed Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Supmed Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supmed Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Supmed Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Supmed Pharmaceutical Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Navin Kumar Verma was appointed as Director on 04 Nov 2022.
Frequently asked questions
Supmed Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 November 2022 (4+ years old) and is registered under CIN U52310DL2022PTC406534.
Supmed Pharmaceutical has 2 current directors:
- Navin Kumar Verma - Director
- Praveen Kumar - Director
The latest financial statements of Supmed Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Supmed Pharmaceutical is U52310DL2022PTC406534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supmed Pharmaceutical was incorporated on 04 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Supmed Pharmaceutical by revenue are Milestone Steels Private Limited, Healthy Organics and Foods Private Limited, Victoria Wines Private Limited, Sui Generis Innovations Private Limited, Mungasaji Krupa Patil Multi Enterprises Private Limited and 5 more, all in the same principal business activity (retail trading).
Navin Kumar Verma was appointed as Director on 04 Nov 2022. Praveen Kumar was appointed as Director on 04 Nov 2022.
The registered office of Supmed Pharmaceutical is at A – 2944 FF Kh No. 97 & 98 Gali No. 43A Som Bazar Pusta – 4 12 Gamri Ext., Delhi, India – 110053.
Supmed Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Supmed Pharmaceutical is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.
Supmed Pharmaceutical can be reached at its registered office: A – 2944 FF Kh No. 97 & 98 Gali No. 43A Som Bazar Pusta – 4 12 Gamri Ext, Delhi, India – 110053.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
